Cargando…

Severe Post-COVID-19 Organizing Pneumonia during Cancer Immunochemotherapy

A 44-year-old man developed coronavirus disease 2019 (COVID-19) pneumonia during immunochemotherapy consisting of carboplatin, paclitaxel, and pembrolizumab for non-small cell lung cancer. Low-grade fever, followed by mild hypoxemia, and febrile neutropenia, were observed, and granulocyte colony-sti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kitahara, Asako, Ebihara, Akinori, Obayashi, Shohei, Horio, Yukihiro, Ono, Yoshitaka, Yoshikawa, Tomohiro, Okada, Naoki, Tanaka, Jun, Takiguchi, Hiroto, Hayama, Naoki, Ito, Yoko, Oguma, Tsuyoshi, Kuwahira, Ichiro, Asano, Koichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107986/ https://www.ncbi.nlm.nih.gov/pubmed/35135922 http://dx.doi.org/10.2169/internalmedicine.8928-21

Ejemplares similares

Asthma exacerbation associated with COVID-19 pneumonia
por: Ono, Yoshitaka, et al.
Publicado: (2021)

Cryptogenic Fibrosing Pleuritis with Rapidly Progressive Restrictive Ventilatory Dysfunction
por: Torii, Ayane, et al.
Publicado: (2022)

Trans-arterial Embolization in a Patient with Unilateral Absence of Pulmonary Artery: Treatment Success and the Four-year Prognosis
por: Ono, Yoshitaka, et al.
Publicado: (2022)

Can MASCC and CISNE scores predict delays of lung cancer chemotherapy after febrile neutropenia?
por: Ono, Yoshitaka, et al.
Publicado: (2022)

Rhabdomyolysis Caused by Gefitinib Overdose
por: Obayashi, Shohei, et al.
Publicado: (2021)

Regression of Lung Squamous Cell Carcinoma after the Withdrawal of Cyclosporin A Combined with Pirfenidone Treatment in a Patient with Idiopathic Pulmonary Fibrosis
por: Takahashi, Mari, et al.
Publicado: (2020)

COVID‐19 vaccine‐associated organizing pneumonia
por: Yoshikawa, Tomohiro, et al.
Publicado: (2022)

Prognosis of acute exacerbation in idiopathic pulmonary fibrosis with pulmonary emphysema: a retrospective cohort study in Japan
por: Horio, Yukihiro, et al.
Publicado: (2022)

Occupational Hypersensitivity Pneumonitis in a Japanese Citrus Farmer
por: Kutsuzawa, Naokata, et al.
Publicado: (2021)

Proportion and clinical characteristics of non-asthmatic non-smokers among adults with airflow obstruction
por: Takiguchi, Hiroto, et al.
Publicado: (2018)

Eosinophilic granulomatosis with polyangiitis after treatment with dupilumab
por: Yamazaki, Kai, et al.
Publicado: (2022)

Transudative Pleural Effusion Associated with Extramedullary Hematopoiesis
por: Enokida, Keito, et al.
Publicado: (2020)

Endobronchial Hamartoma as a Cause of Pneumonia
por: Oguma, Tsuyoshi, et al.
Publicado: (2014)

Clinical contributions of exhaled volatile organic compounds in the diagnosis of lung cancer
por: Oguma, Tsuyoshi, et al.
Publicado: (2017)

Sensitization pattern to environmental allergens in a Japanese population
por: Kitahara, Asako, et al.
Publicado: (2022)

Analysis of key clinical features for achieving complete remission in stage III and IV non-small cell lung cancer patients
por: Aoki, Takuya, et al.
Publicado: (2019)

Current trends of anticancer immunochemotherapy
por: Vacchelli, Erika, et al.
Publicado: (2013)

Dramatic response to immunochemotherapy followed by salvage surgery in an elderly lung cancer patient
por: Okano, Yoshio, et al.
Publicado: (2021)

Empyema associated with Campylobacter curvus infection
por: Horio, Yukihiro, et al.
Publicado: (2017)

Trial Watch: Lenalidomide-based immunochemotherapy
por: Semeraro, Michaela, et al.
Publicado: (2013)

Immunochemotherapy for Richter syndrome: current insights
por: Puła, Bartosz, et al.
Publicado: (2019)

Immunotherapy and immunochemotherapy in combating visceral leishmaniasis
por: Yadagiri, Ganesh, et al.
Publicado: (2023)

Bifidobacterium in anticancer immunochemotherapy: friend or foe?
por: Procaccianti, Giorgia, et al.
Publicado: (2023)

Combination of computed tomography imaging pattern and severity of respiratory failure as factors associated with prognosis for acute exacerbation of idiopathic chronic fibrosing interstitial pneumonia
por: Enokida, Keito, et al.
Publicado: (2023)

Pancreatic insulin release in vitamin C-deficient senescence marker protein-30/gluconolactonase knockout mice
por: Senmaru, Takafumi, et al.
Publicado: (2012)

Adrenal insufficiency in immunochemotherapy for small-cell lung cancer with ectopic ACTH syndrome
por: Nakajima, Hiroki, et al.
Publicado: (2021)

An immunostimulatory dual-functional nanocarrier that improves cancer immunochemotherapy
por: Chen, Yichao, et al.
Publicado: (2016)

ML-02 MULTIAGENT IMMUNOCHEMOTHERAPY, R-MPV-A, FOR PATIENTS WITH SECONDARY CENTRAL NERVOUS SYSTEM LYMPHOMA
por: Nagane, Motoo, et al.
Publicado: (2019)

Immunotherapy and Immunochemotherapy in Visceral Leishmaniasis: Promising Treatments for this Neglected Disease
por: Roatt, Bruno Mendes, et al.
Publicado: (2014)

Drug screening approach combines epigenetic sensitization with immunochemotherapy in cancer
por: Facciotto, Chiara, et al.
Publicado: (2019)

Campylobacter fetus spondylodiscitis during immunochemotherapy for non-Hodgkin's lymphoma
por: Cunha, Jéssica Santos, et al.
Publicado: (2021)

The Feasibility of Virtual Toxicity Assessments in Lymphoma Patients Receiving Immunochemotherapy
por: Runge, John S., et al.
Publicado: (2020)

Real-world efficacy of anti-IL-5 treatment in patients with allergic bronchopulmonary aspergillosis
por: Tomomatsu, Katsuyoshi, et al.
Publicado: (2023)

Novel combination immunochemotherapy beyond CD20 for B-cell lymphomas
por: Yi, Jun Ho
Publicado: (2021)

Diverse effects of chemotherapeutic agents on immune cell function and implications in immunochemotherapy
por: Glorieux, Christophe, et al.
Publicado: (2021)

Evolving frontline immunochemotherapy for mantle cell lymphoma and the impact on survival outcomes
por: Castellino, Alessia, et al.
Publicado: (2022)

Hypofractionated radiotherapy with immunochemotherapy for extensive-stage small-cell lung cancer
por: Liu, Chaoyuan, et al.
Publicado: (2023)

A case of simultaneous occurrence of hepatitis and pancreatitis during the combination immunochemotherapy for non-small cell lung carcinoma
por: Tanaka, Satoshi, et al.
Publicado: (2020)

Senescence marker protein-30/gluconolactonase deficiency exacerbates diabetic nephropathy through tubular injury in a mouse model of type 1 diabetes
por: Okada, Hiroshi, et al.
Publicado: (2015)

Immunochemotherapy Disrupts Peripherally Located Lung Squamous Cell Carcinoma Resulting in Pleuritis: A Report of Two Cases, Case Report
por: Kunimasa, Kei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eq7uj07ncq55fdgmenu9l0sbbf